glp-1 brain fog mimetics and cognition GLP-1s vs. traditional weight loss:

A quieter secondary shift is emerging in the resale economy

Research demonstrates that lifestyle changes alone cannot fully offset the biological rebound when GLP-1 medications stop

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by Eli Lilly could offer an intriguing off-ramp

Dana used dermal fillers which can restore structure and volume to the cheeks, temples, and under-eye area relatively quickly, with results that look refreshed rather than overdone

As the clock ticks down on compliance deadlines, it is critical that compounding pharmacies and telehealth companies that prescribe GLP-1 medications review their practices, including pharmacy relationships, drug fulfillment, and patient-facing materials, to ensure they are prepared to adhere to the FDAs regulations for semaglutide and other compounded drugs

Similar findings were reported in a prospective perioperative gastric ultrasonography study, in which semaglutide use within 10 days of elective procedures was associated with a markedly higher prevalence of increased residual gastric content compared with controls (40% vs